Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.31%) to 10353.84, DAX (0.11%) to 24987.85, CAC40 +0.06% to 8327.88, STOXX 600 (0.07%) to 620.97

Feb 10 ,2026

  • Synopsis:

    • European equity markets finished mixed. Oil names and insurance the worst performing sectors, while chemicals, auto/parts and media outperform. US equity markets mixed in midday trading. Treasuries firmer with curve flattening; yields down 4-6 bp. Gilts 5 bps lower at 4.48%. Bund down 4 bps at 2.81%. JGBs performing well after coming under pressure in prior session. Dollar sharply lower versus Japanese yen, firmer elsewhere. Gold, silver down. Bitcoin futures down 3.9%. WTI crude down 0.2%.

    • In Europe, supportive corporate news and upbeat macro-outlook providing traction after yesterday's jump in Eurozone investor confidence. Quiet macro calendar in Europe on Tuesday. UK BRC update see boost in January retail sales by 2.7% y/y versus 2.6% a year ago, above 12-month average of 2.3%.. UK politics continues to fuel fluctuations in UK assets. PM Starmer secured the support of cabinet ministers after resignation of key aides resigned in recent days, which may offer a temporary reprieve from speculation of potential leadership challenge. French President Macron used series of press interviews to call for more assertive European economic policy amid recent Trump attacks; ahead of a two-day EU summit, Macron emphasized time for launch of joint borrowing capacity with Eurobonds and highlighted joint borrowing would fund strategic investments and tackle hegemony of the dollar.

    • In European corporate news highlights, in finance sector, Barclays (BARC.LN) reported better-than-expected FY numbers and added group was on track to deliver 2026 targets and announced new targets to 2028. Further in the UK, shares of Standard Chartered (STAN.LN) traded lower after CFO Diego De Giorgi announced he was stepping down to pursue external opportunity, effective immediately. Mediobanca (MB.IM) Q2 net income beat expectations; while UniCredit (UCG.IM) completed second tranche worth ~€1.77B and share were also upgraded to overweight from equal-weight at Morgan Stanley overnight. Midday, Commerzbank (CBK.GR) reported prelim. FY number and announced dividend proposal and share buyback.

    • In health, AstraZeneca (AZN.LN) reported Q4 EPS as expected and guided for core EPS to increase by low doubt-digit percentage for 2026. Koninklijke Philips (PHIA.NA ) shares are over +8% higher post strong Q4 and upbeat guidance.

    • In other notable releases, BP (BP.LN) shares lower following Q4 results, trimmed capex guidance and suspended share buyback. Kering (KER.FP) shares over +11% higher at this time post better-than-expected Q4 sales, though recurring operating income and net income below expectations. Salzgitter (SZG.GR) reports prelim. FY numbers and provided FY26 guidance.

    • Light in M&A headlines, overnight media reported Anglo American (AAL.LN) considers sale of De Beers to public-private consortium to be the likely outcome of sale process. Sanofi (SAN.FP) completes acquisition of Dynavax (DVAX) and Prysmian (PRY.IM) closes acquisition of ACSM.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Chemicals +3.00%, Autos & Parts +2.54%, Media +1.72%, Persnl & HHold Goods +1.12%, Food & Beverage +1.08%, Real Estate +1.02%, Health Care +0.77%, Utilities +0.51%, Retail +0.40%, Basic Resources +0.21%, Technology +0.07%

      • Underperformers:

        • Insurance (1.80%), Oil & Gas (1.62%), Banks (1.19%), Financial Svcs (0.44%), Travel & Leisure (0.39%), Telecom (0.37%), Ind Goods & Svcs (0.26%), Construct & Mtls (0.26%)

    • Macro:

      • BoE:

        • US-China trade wars fueling UK inflation via higher export prices, says BOE policymaker (Bloomberg)

      • UK:

        • Record UK support for tax and spending cuts highlights deepening political divide (FT)

        • UK retail sales rebound in January after sluggish Christmas period (link)

        • UK PM Starmer survives immediate resignation calls amid Epstein scandal fallout (Bloomberg, link)

        • UK Treasury vows tighter security after budget document leaks and early releases (Bloomberg)

      • Germany:

        • Auto industry in 'crisis' as investments, jobs move abroad, lobby says (Reuters )

      • Geopolitics:

        • Macron warns EU-US tensions over Greenland and tech persist, urges economic revolution (FT)

        • European Parliament fast-tracks vote on €90B Ukraine war loan (Politico)

        • EU's Kallas to propose concessions that Europe should demand from Russia (Reuters )

    • Peripheral markets:

      • Italy:

        • EU has adopted Italy migrant strategy says Procaccini (ANSA )

      • Norway:

        • Surprise inflation jump cuts chances of more easing (Bloomberg )

        • Norway parliament to appoint rare outside probe of ministry's Epstein links (Reuters )

      • Greece:

        • Greece and Malta hesitate over EU's Russia oil services ban (Bloomberg )

    • Company news:

      • Notable Gainers

        • +13.3% SDIP.B.SS (Sdiptech SEK189.20, +22.20) -- Q4 earnings

        • +12.9% THULE.SS (Thule Group SEK245.60, +28.00) -- Q4 earnings

        • +12.2% PHIA.NA (Koninklijke Philips €27.68, +3.01) -- Q4 earnings

        • +10.8% AKE.FP (Arkema €65.35, +6.35) -- Goldman Sachs upgrade

        • +10.7% LXS.GR (Lanxess €21.50, +2.08) -- Goldman Sachs upgrade

        • +10.1% KER.FP (Kering €286.00, +26.30) -- FY earnings

        • +8.9% MCOV.B.SS (Medicover SEK220.00, +18.00) -- FY earnings

        • +7.2% SY1.GR (Symrise €76.80, +5.16) -- Goldman Sachs upgrade

        • +6.9% ALCOX.FP (Nicox €0.37, +0.02) -- study update

        • +6.5% AIXA.GR (Aixtron €22.50, +1.38) -- Jefferies upgrade

        • +6.3% SATS.NO (SATS ASA NOK42.50, +2.50) -- Q4 earnings

        • +5.9% SZG.GR (Salzgitter €54.15, +3.00) -- prelim earnings

        • +5.7% EVK.GR (Evonik Industries €15.85, +0.86) -- Goldman Sachs upgrade

        • +5.5% AMS.SW (ams-OSRAM CHF8.66, +0.46) -- Q4 earnings

        • +5.3% CCH.LN (Coca-Cola HBC £45.06, +2.28) -- FY earnings

        • +4.9% BAS.GR (BASF SE €51.04, +2.38) -- BASF criticizes EU emissions trading system; calls it obsolete and warns it is hurting Europe's chemical sector - FT

        • +4.3% TYRES.FH (Nokian Renkaat €11.07, +0.46) -- earnings; strategy

        • +4.0% BWY.LN (Bellway £26.46, +1.02) -- H1 trading update

        • +3.7% MAB.LN (Mitchells & Butlers £2.84, +0.10) -- Deutsche Numis upgrade

        • +2.5% SAN.FP (Sanofi €82.32, +2.03) -- completes acquisition of Dynavax (DVAX)

        • +2.3% MT.NA (ArcelorMittal €52.90, +1.18) -- confirms construction of electric arc furnace in Dunkirk, France

        • +1.9% SIGHT.FP (GenSight Biologics €0.08, -0.00) -- study update

        • +1.6% WIHL.SS (Wihlborgs Fastigheter SEK93.80, +1.50) -- Q4 earnings

        • +1.5% AB.FP (AB Science €1.39, +0.02) -- FDA has granted the status of Minor Use in Major Species for Masivet in the treatment of canine mast cell tumors

      • Notable Decliners

        • -58.2% FARN.LN (Faron Pharmaceuticals £0.69, -0.96) -- €40M rights offering; Inderes downgrade

        • -40.6% NELLY.SS (Nelly Group SEK76.30, -51.90) -- Q4 earnings

        • -24.6% OPTOMED.FH (Optomed €3.00, -0.98) -- FY earnings

        • -15.9% ITAB.SS (ITAB Shop Concept SEK15.36, -2.90) -- Q4 earnings

        • -6.3% BP.LN (BP £4.47, -0.30) -- Q4 earnings; to suspend share buyback

        • -6.2% ALIG.SS (Alimak Group SEK130.60, -8.60) -- Q4 earnings

        • -6.1% TMV.GR (TeamViewer €5.54, -0.36) -- Q4 earnings

        • -5.8% STAN.LN (Standard Chartered £17.89, -1.10) -- CFO steps down

        • -5.0% TUI1.GR (TUI Group €8.88, -0.47) -- Q1 earnings

        • -4.8% NDX1.GR (Nordex €32.12, -1.62) -- Citi downgrade

        • -3.6% BVC.LN (BATM Advanced Communications £0.15, -0.01) -- disposes Laborator AMS for $1M in cash

        • -3.2% BMPS.IM (Banca Monte dei Paschi di Siena €8.80, -0.30) -- prelim Q4 earnings

        • -3.2% UMI.BB (Umicore €19.33, -0.63) -- Goldman Sachs downgrade

        • -3.1% BAR.BB (Barco €11.09, -0.35) -- FY earnings

        • -2.6% ETTE.FH (Etteplan €9.16, -0.24) -- initiates change negotiations in Software and Embedded Solutions service area

        • -2.6% MULTI.NO (Multiconsult NOK166.00, -4.50) -- Q4 earnings

        • -1.6% ATEA.NO (Atea NOK146.00, -2.40) -- Q4 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: Voestalpine (VOE.AV), BAWAG Group (BG.AV)

        • Benelux: Heineken (HEIA.NA), Koninklijke Ahold Delhaize (AD.NA), ABN AMRO Bank (ABN.NA), Randstad (RAND.NA)

        • Finland: Kojamo (KOJAMO.FH), Sanoma (SANOMA.FH), Kempower (KEMPOWR.FH), Finnair (FIA1S.FH), Revenio Group (REG1V.FH), Raisio (RAIVV.FH), Anora Group (ANORA.FH), Taaleri (TAALA.FH), NoHo Partners (NOHO.FH), Sitowise Group (SITOWS.FH), Siili Solutions (SIILI.FH)

        • France: TotalEnergies (TTE.FP), EssilorLuxottica (EL.FP), Dassault Systemes (DSY.FP), Michelin (ML.FP), Rexel (RXL.FP), Lectra (LSS.FP), Linedata Services (LIN.FP)

        • Germany: Siemens Energy (ENR.GR), Commerzbank (CBK.GR), CECONOMY (CEC.GR), Douglas (DOU.GR), thyssenkrupp nucera (NCH2.GR)

        • Norway: Aker BP (AKRBP.NO), Mowi (MOWI.NO), Yara International (YAR.NO), Storebrand (STB.NO), Wallenius Wilhelmsen (WAWI.NO), Wilh. Wilhelmsen Holding (WWI.NO), Entra (ENTRA.NO), Elkem (ELK.NO), Public Property Invest (PUBLI.NO), Norbit (NORBT.NO), Odfjell (ODF.NO), Kid (KID.NO), ABG Sundal Collier Holding (ABG.NO), 2020 Bulkers (2020.NO), Selvaag Bolig (SBO.NO), Spir Group (SPIR.NO)

        • Other: Arion Banki (ARION.IR), Norilsk Nickel (GMKN.RU)

        • Southern Europe: Banca Generali (BGN.IM), Cementir Holding (CEM.IM), Banca Ifis (IF.IM)

        • Sweden: Latour Investment (LATO.B.SS), Sweco (SWEC.B.SS), Karnov Group (KAR.SS), MIPS (MIPS.SS), Storytel (STORY.B.SS), Acast (ACAST.SS), Coor Service Management Holding (COOR.SS), Bredband2 i Skandinavien (BRE2.SS), ByggPartner Gruppen (BYGGP.SS), Eolus Aktiebolag (EOLU.B.SS), Net Insight (NETI.B.SS), Profoto Holding (PRFO.SS), Mendus (IMMU.SS), Boule Diagnostics (BOUL.SS), IRLAB Therapeutics (IRLAB.A.SS), Arctic Falls (ARFA.SS)

        • Switzerland: SGS (SGSN.SW), Schindler Holding (SCHP.SW)

        • UK: Barratt Redrow (BTRW.LN), Renishaw (RSW.LN), PZ Cussons (PZC.LN), MJ Gleeson (GLE.LN)

      • Trading Update:

        • France: Neurones (NRO.FP), Claranova (CLA.FP)

      • Traffic: Heathrow Airport (+HTR.LN)

      • CMD/Events: Nokian Renkaat (TYRES.FH), PZ Cussons (PZC.LN), Medicover (MVOV.B.SS), Molten Ventures (GROW.LN)

  • Data:

    • Economics:

      • France Q4 Unemployment Rate 7.9% vs consensus 7.8% and prior 7.7%

      • Austria Dec Industrial Production (3.3%) y/y vs consensus +1.1% and prior revised (0.1%) from (0.3%)

      • Denmark Jan CPI +0.8% y/y vs consensus +1.8% and prior +1.9%; (0.6%) m/m vs consensus +0.5% and prior (0.4%)

      • Finland Dec Industrial Production +2.0% y/y vs consensus +2.1% and prior revised +1.7% from +1.9%

      • Greece Dec Industrial Production +3.9% y/y vs consensus +2.3% and prior revised +4.3% from +2.6%

      • Netherlands Dec Manufacturing Production +0.5% m/m vs consensus (0.2%) and prior revised (1.0%) from (0.5%)

      • Norway Jan CPI +3.6% y/y vs consensus +3.1% and prior +3.2%; +0.6% m/m vs consensus +0.1% and prior +0.1%

      • Sweden Dec Industrial Production +4.2% y/y vs consensus +4.0% and prior +4.2%

    • Markets:

      • WTI Crude (Mar 26): ($0.31) or (0.48%) to $64.05

      • €-$ (0.0014) or (0.12%) to 1.1904

      • £-$ (0.0028) or (0.20%) to 1.3668

      • €-£ +0.0008 to 0.8710

      • S&P 500 +0.05%

      • Performance year-to-date

        • FTSE 100: +4.25%

        • DAX: +2.03%

        • CAC: +2.19%

        • MIB: +4.13%

        • Stoxx 600: +4.86%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE